251 related articles for article (PubMed ID: 8416578)
1. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation.
Jabour BA; Choi Y; Hoh CK; Rege SD; Soong JC; Lufkin RB; Hanafee WN; Maddahi J; Chaiken L; Bailet J
Radiology; 1993 Jan; 186(1):27-35. PubMed ID: 8416578
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.
Anzai Y; Carroll WR; Quint DJ; Bradford CR; Minoshima S; Wolf GT; Wahl RL
Radiology; 1996 Jul; 200(1):135-41. PubMed ID: 8657901
[TBL] [Abstract][Full Text] [Related]
3. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.
Braams JW; Pruim J; Freling NJ; Nikkels PG; Roodenburg JL; Boering G; Vaalburg W; Vermey A
J Nucl Med; 1995 Feb; 36(2):211-6. PubMed ID: 7830116
[TBL] [Abstract][Full Text] [Related]
4. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Mukherji SK; Drane WE; Mancuso AA; Parsons JT; Mendenhall WM; Stringer S
Radiology; 1996 Jun; 199(3):761-6. PubMed ID: 8638002
[TBL] [Abstract][Full Text] [Related]
5. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET.
Rege SD; Chaiken L; Hoh CK; Choi Y; Lufkin R; Anzai Y; Juillard G; Maddahi J; Phelps ME; Hawkins RA
Radiology; 1993 Dec; 189(3):807-12. PubMed ID: 8234708
[TBL] [Abstract][Full Text] [Related]
6. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
7. Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG.
Uematsu H; Sadato N; Yonekura Y; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Yamamoto K; Hayashi N; Ishii Y
J Nucl Med; 1998 Dec; 39(12):2121-7. PubMed ID: 9867154
[TBL] [Abstract][Full Text] [Related]
8. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
Greven KM; Keyes JW; Williams DW; McGuirt WF; Joyce WT
Cancer; 1999 Jul; 86(1):114-8. PubMed ID: 10391570
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy.
Bailet JW; Abemayor E; Jabour BA; Hawkins RA; Ho C; Ward PH
Laryngoscope; 1992 Mar; 102(3):281-8. PubMed ID: 1545657
[TBL] [Abstract][Full Text] [Related]
11. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
Platzek I
PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244
[TBL] [Abstract][Full Text] [Related]
12. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers.
Rege S; Maass A; Chaiken L; Hoh CK; Choi Y; Lufkin R; Anzai Y; Juillard G; Maddahi J; Phelps ME
Cancer; 1994 Jun; 73(12):3047-58. PubMed ID: 8200003
[TBL] [Abstract][Full Text] [Related]
13. [Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Head and neck cancer].
Nakasone Y; Mogi K; Endo K
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 May; 62(6):258-64. PubMed ID: 12073631
[TBL] [Abstract][Full Text] [Related]
14. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.
Lapela M; Grénman R; Kurki T; Joensuu H; Leskinen S; Lindholm P; Haaparanta M; Ruotsalainen U; Minn H
Radiology; 1995 Oct; 197(1):205-11. PubMed ID: 7568825
[TBL] [Abstract][Full Text] [Related]
15. Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck.
Mukherji SK; Drane WE; Tart RP; Landau S; Mancuso AA
AJNR Am J Neuroradiol; 1994 Nov; 15(10):1837-42. PubMed ID: 7863932
[TBL] [Abstract][Full Text] [Related]
16. Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images.
Wong WL; Hussain K; Chevretton E; Hawkes DJ; Baddeley H; Maisey M; McGurk M
Am J Surg; 1996 Dec; 172(6):628-32. PubMed ID: 8988664
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomographic imaging of the head and neck.
Lee TH; Anzai Y; Huda A; Rege S; Hawkins R; Lufkin RB
West J Med; 1993 Jul; 159(1):72. PubMed ID: 8351912
[No Abstract] [Full Text] [Related]
18. [Positron emission tomography in head and neck oncology: five cases].
Courtois A; Foehrenbach H; Maszelin P; De Dreuille O; Garcia D; Kossowski M; Merlet P; Gaillard JF; Poncet JL
Ann Otolaryngol Chir Cervicofac; 2001 Sep; 118(4):254-60. PubMed ID: 11679846
[TBL] [Abstract][Full Text] [Related]
19. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
McGuirt WF; Williams DW; Keyes JW; Greven KM; Watson NE; Geisinger KR; Cappellari JO
Laryngoscope; 1995 Apr; 105(4 Pt 1):373-5. PubMed ID: 7715380
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomographic imaging of head and neck lesions.
Sakamoto H; Nakai Y; Ohashi Y; Okamura T; Ochi H
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S123-6. PubMed ID: 9065645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
